Psoriatic arthritis in Canadian Clinical Practice: The PsA assessment in rheumatology

Journal of Rheumatology

Volumn 39, Issue 9, 2012, Pages 1850-1853

  Gladman, Dafna D ^a,b,c   Chandran, Vinod ^a,c   Thavaneswaran, Arane ^c   Zummer, Michel ^d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c TORONTO WESTERN HOSPITAL   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Activity; Community care; Damage; Psoriatic arthritis; Treatment

Indexed keywords

ABATACEPT; ADALIMUMAB; ALEFACEPT; ANTIMALARIAL AGENT; AZATHIOPRINE; CYCLOSPORIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; PSORALEN DERIVATIVE; SALAZOSULFAPYRIDINE; STEROID; USTEKINUMAB;

ADULT; ARTICLE; CANADA; CLINICAL ASSESSMENT; CLINICAL DECISION MAKING; CLINICAL EXAMINATION; CLINICAL PRACTICE; COHORT ANALYSIS; DEMOGRAPHY; DISEASE ACTIVITY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; JOINT INJURY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL SOCIETY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RHEUMATOLOGY; SKIN DISEASE;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; CANADA; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; RHEUMATOLOGY; SEVERITY OF ILLNESS INDEX;

EID: 84865720963     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.120282     Document Type: Article

References (10)

1. Gladman DD, Farewell VT. Progression in psoriatic arthritis: Role of time varying clinical indicators. J Rheumatol 1999;26:2409-13.
2. Queiro-Silva R, Torre-Alonso JC, Tinture-Eguren T, Lopez-Lagunas I. A polyarticular onset predicts erosive and deforming disease in psoriatic arthritis. Ann Rheum Dis 2003;62:68-70.
3. McHugh NJ, Balachrishnan C, Jones SM. Progression of peripheral joint disease in psoriatic arthritis: A 5-yr prospective study. Rheumatology 2003;42:778-83.
4. Kane D, Stafford L, Bresnihan B, FitzGerald O. A prospective, clinical and radiological study of early psoriatic arthritis: An early synovitis clinic experience. Rheumatology 2003;42:1460-8.
5. Bond SJ, Farewell VT, Schentag CT, Gladman DD. Predictors for radiological damage in psoriatic arthritis. Results from a single centre. Ann Rheum Dis 2007;66:370-6.
6. Wong K, Gladman DD, Husted J, Long J, Farewell VT. Mortality studies in psoriatic arthritis. Results from a single centre. I. Risk and causes of death. Arthritis Rheum 1997;40:1868-72.
7. Ali Y, Tom BD, Schentag CT, Farewell VT, Gladman DD. Improved survival in psoriatic arthritis with calendar time. Arthritis Rheum 2007;56:2708-14.
8. Buckley C, Cavill C, Taylor G, Kay H, Waldron N, Korendowych E, et al. Mortality in psoriatic arthritis - A single-center study from the UK. J Rheumatol 2010;37:2141-4.
9. Shbeeb M, Uramoto KM, Gibson LE, O'Fallon WM, Gabriel SE. The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991. J Rheumatol 2000;27:1247-50.
10. Taylor WJ, Gladman DD, Helliwell PS, Marchesoni A, Mease P, Mielants H. Classification criteria for psoriatic arthritis: Development of new criteria from a large international study. Arthritis Rheum 2006;54:2665-73.